Granulomatous Disease Chronic X Linked C1844376
The most common form of chronic granulomatous disease, primarily affecting males due to its genetic inheritance pattern. Causes vulnerability to specific infections requiring lifelong monitoring.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Pneumonia with catalase-positive organisms
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Recurrent bacterial and fungal infections
(immunologic)Granulomatous colitis
(gastrointestinal)Hepatic abscess
(hepatobiliary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Prophylactic Antibiotic Therapy
Daily prophylactic antibiotics such as trimethoprim-sulfamethoxazole are used to prevent bacterial infections in patients with Chronic Granulomatous Disease, as their phagocytes cannot effectively kill certain bacteria.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Antifungal Prophylaxis
Preventive antifungal therapy, typically with itraconazole or voriconazole, reduces the risk of invasive fungal infections which are particularly dangerous in this patient population.
Additional treatment options
Infection Prevention Strategies
Comprehensive lifestyle modifications including avoiding exposure to catalase-positive organisms, gardening soil, and poorly maintained water sources significantly reduces infection risk.
lifestyleRegular Infection Surveillance
Frequent clinical monitoring with periodic laboratory assessments helps detect early signs of infection or inflammatory complications before they become severe.
monitoringHematopoietic Stem Cell Transplantation
HSCT can potentially cure Chronic Granulomatous Disease by replacing defective phagocytes with healthy donor cells, though it carries significant risks and requires careful patient selection.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Granulomatous Disease Chronic X Linked C1844376?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Granulomatous Disease Chronic X Linked C1844376. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy